Lacosamide 65862-0749-03
- Manufacturer
- Aurobindo Pharma Limited
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- January 5, 2023
- Listing Expires
- December 31, 2027
- Application
- ANDA204994
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 150 mg/1 |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
65862-0749-03Selected3 BLISTER PACK in 1 CARTON (65862-749-03) / 10 TABLET, FILM COATED in 1 BLISTER PACK (65862-749-10)
Other packages for this product(1)
60 TABLET, FILM COATED in 1 BOTTLE (65862-749-60)